BLOOD-BASED EXTRACELLULAR MATRIX BIOMARKERS CAN IDENTIFY ENDOTYPES OF PATIENTS WITH AXSPA AND RESPONDERS TO ADALIMUMAB TREATMENT

被引：0
|
作者：
Port, H. [1 ]
Christiansen, F. [2 ]
Nielsen, S. Holm [2 ]
Frederiksen, P. [2 ]
Bay-Jensen, A. C. [2 ]
Karsdal, M. [2 ]
Sorensen, I. J. [3 ]
Ostergaard, M. [3 ,4 ]
Pedersen, S. Juhl [4 ]
机构：
[1] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark
[2] Nord Biosci AS, Immunosci, Copenhagen, Denmark
[3] Univ Copenhagen, Clin Med, Copenhagen, Denmark
[4] Rigshosp, Ctr Arthrit Res, Glostrup, Denmark
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
D O I：
10.1136/annrheumdis-2023-eular.408
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0245
引用
收藏
页码：356 / 357
页数：2
相关论文
共 50 条
  • [1] Identification of patient endotypes and adalimumab treatment responders in axial spondyloarthritis using blood-derived extracellular matrix biomarkers
    Port, Helena
    Christiansen, Frederik
    Nielsen, Signe Holm
    Frederiksen, Peder
    Bay-Jensen, Anne-C
    Karsdal, Morten Asser
    Seven, Sengul
    Sorensen, Inge Juul
    Loft, Anne Gitte
    Madsen, Ole Rintek
    Ostergaard, Mikkel
    Pedersen, Susanne J.
    RMD OPEN, 2024, 10 (01):
  • [2] Blood-based biomarkers of extracellular matrix turnover are elevated in patients with psoriasis compared with healthy controls
    Johansen, Mila Broby
    Nielsen, Signe Holm
    Port, Helena
    Todberg, Tanja
    Lovendorf, Marianne Bengtson
    Skov, Lone
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [3] A blood-based gene expression assay that can identify patients with multiple sclerosis
    Greenberg, B.
    Bigwood, D.
    Eastman, E.
    JOURNAL OF NEUROLOGY, 2008, 255 : 79 - 79
  • [4] Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa
    Wang, Song
    Bager, Cecilie L.
    Karsdal, Morten A.
    Chondros, Dimitrios
    Taverna, Darin
    Willumsen, Nicholas
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [5] Blood-based extracellular matrix biomarkers as predictors of survival in patients with metastatic pancreatic ductal adenocarcinoma receiving pegvorhyaluronidase alfa
    Song Wang
    Cecilie L. Bager
    Morten A. Karsdal
    Dimitrios Chondros
    Darin Taverna
    Nicholas Willumsen
    Journal of Translational Medicine, 19
  • [6] Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma
    Hurkmans, Daan P.
    Jensen, Christina
    Koolen, Stijn L. W.
    Aerts, Joachim
    Karsdal, Morten Asser
    Mathijssen, Ron H. J.
    Willumsen, Nicholas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [7] Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders
    Preece, Rhian Lauren
    Han, Sung Yeon Sarah
    Bahn, Sabine
    EXPERT REVIEW OF PROTEOMICS, 2018, 15 (04) : 325 - 340
  • [8] Blood-based biomarkers of frailty in older patients with cancer
    Akagunduz, Baran
    Ergun, Yakup
    Akagunduz, Digdem Dogan
    Akbas, Nergis
    Akagunduz, Dilara
    Karaoglu, Aziz
    Soysal, Pinar
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2025, 19 (01) : 25 - 32
  • [9] Blood-Based DNA Methylation Biomarkers to Identify Risk and Progression of Cardiovascular Disease
    Willmer, Tarryn
    Mabasa, Lawrence
    Sharma, Jyoti
    Muller, Christo J. F.
    Johnson, Rabia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [10] Extracellular sulfatases as potential blood-based biomarkers for early detection of lung cancer
    Yang, Yi-Wei
    Jablons, David M.
    Lemjabbar-Alaoui, Hassan
    EXPERIMENTAL LUNG RESEARCH, 2021, 47 (06) : 261 - 279
12345